Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

C2 Therapeutics, Inc. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

78 daysmedian FDA review time
391 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K163684C2 CryoBalloon Ablation SystemC2 Therapeutics, Inc.2018-01-233910
K161202C2 Cryoballoon Ablation SystemC2 Therapeutics, Inc.2017-01-052521
K160994C2 CryoBalloon Focal Pear CatheterC2 Therapeutics, Inc.2016-05-19410
K152329Coldplay Cryoballoon; Focal Ablation System, Full Ablation SC2 Therapeutics, Inc.2016-04-132391
K153541Coldplay CryoBalloon® Ablation SystemC2 Therapeutics, Inc.2016-01-07280
K152140Boa Endoscopic ValveC2 Therapeutics, Inc.2015-10-13710
K151054Coldplay Full CryoBalloon Ablation System and Coldplay SwipeC2 Therapeutics, Inc.2015-07-07780

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda